Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

SHE:002262 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,416	2,159	1,532	1,608	1,402
Trading Asset Securities	2,373	1,335	1,452	1,058	837
Cash & Short-Term Investments	3,789	3,494	2,984	2,666	2,239
Cash Growth	8.46%	17.08%	11.94%	19.05%	13.06%
Accounts Receivable	1,496	1,054	843.93	720.49	609.22
Other Receivables	49.07	41.84	42.52	27.61	19.35
Receivables	1,545	1,095	886.45	748.09	628.57
Inventory	661.39	628.64	716.34	604.33	433.86
Prepaid Expenses	5.45	0	0	4.81	-
Other Current Assets	57.84	36.63	63.4	19.96	17.73
Total Current Assets	6,060	5,255	4,650	4,043	3,320
Property, Plant & Equipment	1,609	1,496	1,304	1,158	1,034
Long-Term Investments	125.31	106.77	118.61	130.41	81.23
Other Intangible Assets	232.09	190.47	111.1	95.98	101.04
Long-Term Deferred Tax Assets	55.39	58.32	36.95	30.66	31.2
Long-Term Deferred Charges	263.61	128.03	131.88	80.51	25.95
Other Long-Term Assets	95.2	94.05	128.51	158.09	155.18
Total Assets	8,440	7,328	6,481	5,697	4,748
Accounts Payable	568.35	277.2	255.74	267.17	165.19
Accrued Expenses	180.54	296.13	297.36	53.09	38.73
Short-Term Debt	15	55	30	38	38
Current Portion of Leases	20.18	20.86	20.63	25.01	-
Current Income Taxes Payable	91.28	84.1	83.5	80.85	97.91
Current Unearned Revenue	41.53	26.49	26.7	24.11	41.07
Other Current Liabilities	149.37	54.26	80.02	193.72	194.05
Total Current Liabilities	1,066	814.03	793.94	681.96	574.95
Long-Term Debt	0.23	0.23	0.23	0.23	0.23
Long-Term Leases	33.87	35.56	41.91	47.67	-
Long-Term Unearned Revenue	41.41	53.87	58.05	63.6	67.77
Long-Term Deferred Tax Liabilities	0.11	1.46	3.3	-	-
Other Long-Term Liabilities	24.64	12.95	-	-	-
Total Liabilities	1,166	918.09	897.43	793.45	642.94
Common Stock	1,016	1,008	1,008	1,008	1,008
Additional Paid-In Capital	244.18	102.99	119.41	119.41	49.85
Retained Earnings	6,138	5,317	4,481	3,783	3,086
Treasury Stock	-98.86	-	-	-	-35.32
Comprehensive Income & Other	0.87	6.75	13.1	10.95	15.09
Total Common Equity	7,300	6,434	5,622	4,921	4,123
Minority Interest	-26.81	-24.03	-37.79	-16.96	-17.5
Shareholders' Equity	7,274	6,410	5,584	4,904	4,105
Total Liabilities & Equity	8,440	7,328	6,481	5,697	4,748
Total Debt	69.27	111.64	92.77	110.91	38.23
Net Cash (Debt)	3,720	3,382	2,891	2,555	2,201
Net Cash Growth	9.99%	16.98%	13.16%	16.08%	13.31%
Net Cash Per Share	3.68	3.36	2.86	2.53	2.17
Filing Date Shares Outstanding	1,016	1,008	1,008	1,008	1,008
Total Common Shares Outstanding	1,016	1,008	1,008	1,008	1,008
Working Capital	4,993	4,441	3,856	3,361	2,745
Book Value Per Share	7.18	6.39	5.58	4.88	4.09
Tangible Book Value	7,068	6,244	5,510	4,825	4,022
Tangible Book Value Per Share	6.96	6.20	5.47	4.79	3.99
Buildings	613.6	599.08	593.38	569.55	604.46
Machinery	1,546	1,341	1,251	1,088	934.72
Construction In Progress	309.38	293.76	92.07	17.21	3.7

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.